QS Investors’s Elanco Animal Health ELAN Stock Holding History

QS Investors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$270K	Hold	7,758	–	–	﹤0.01%	971
2021 Q1	$229K	Hold	7,758	–	–	﹤0.01%	1071
2020 Q4	$238K	Sell	7,758 -1,542	-17%	-$47K	﹤0.01%	1065
2020 Q3	$260K	Hold	9,300	–	–	﹤0.01%	972
2020 Q2	$200K	Hold	9,300	–	–	﹤0.01%	1132
2020 Q1	$209K	Hold	9,300	–	–	﹤0.01%	1053
2019 Q4	$275K	Hold	9,300	–	–	﹤0.01%	1107
2019 Q3	$248K	Hold	9,300	–	–	﹤0.01%	1148
2019 Q2	$315K	Buy	9,300 +4,400	+90%	+$143K	﹤0.01%	1103
2019 Q1	$158K	Buy	+4,900	New	+$151K	﹤0.01%	1285

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QS Investors's ELAN Position: Q2 2021 in Review

QS Investors held its Elanco Animal Health (ELAN) position steady in Q2 2021 at 7,758 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

QS Investors first reported a position in ELAN in Q1 2019 and has held it in 10 quarters since. The position peaked at $315K in Q2 2019. 479 funds tracked by Wall St. Rank hold ELAN as of Q2 2021.

QS Investors held 7,758 shares of Elanco Animal Health worth $270K as of Q2 2021.
QS Investors left its Elanco Animal Health share count unchanged in Q2 2021.
Elanco Animal Health made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #971 holding.
QS Investors first reported a position in Elanco Animal Health in Q1 2019 and has held it in 10 quarters since.
QS Investors's Elanco Animal Health position peaked at $315K in Q2 2019.
479 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.